Brief: Cipher Pharmaceuticals reports Q2 revenue of $9.9 million
Aug 11 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharmaceuticals reports Q2 2017 financial results
* Q2 earnings per share $0.17 from continuing operations
* Q2 revenue rose 16 percent to $9.9 million
* Q2 earnings per share view $0.17, revenue view $8.3
million -- Thomson Reuters I/B/E/S
Source text for Eikon: ID:nCNWn06fQa
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million